FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nancy Brown

Research Profile

Chemicals & Drugs

Disorders

Physiology

Co-author Network

Publications

TOP 3
J M Balaguer; Stephen K Ball; Nancy Brown; John G Byrne; Michael R Petracek; Chang Yu; Mias Pretorius
Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.
C C White; R A Wilke; L Adrienne Cupples; Elliott P Dawson; Q Feng; J V Gainer; Nancy Brown
CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
F T Billings; Nancy Brown; John G Byrne; Yu C; Michael R Petracek; J M Balaguer; P Wright; Mias Pretorius
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nancy Brown (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J M Balaguer; Stephen K Ball; Nancy Brown; John G Byrne; Michael R Petracek; Chang Yu; Mias Pretorius
Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.
Clinical pharmacology and therapeutics 2013;93(4):326-34.
2013: C C White; R A Wilke; L Adrienne Cupples; Elliott P Dawson; Q Feng; J V Gainer; Nancy Brown
CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
The pharmacogenomics journal 2013;13(1):44-51.
2012: F T Billings; Nancy Brown; John G Byrne; Yu C; Michael R Petracek; J M Balaguer; P Wright; Mias Pretorius
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass.
Clinical pharmacology and therapeutics 2012;91(6):1065-73.
2011: James M Luther; Alvin C Powers; D H Wasserman; T T Whitfield; C Dai; Hyung-Suk Kim; M T Kreger; P Luo; Marcela Brissova; Nancy Brown
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.
Diabetologia 2011;54(8):2152-63.
2010: Frederic T Billings; Mias Pretorius; Edward D Siew; Chang Yu; Nancy Brown
Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery.
Journal of cardiothoracic and vascular anesthesia 2010;24(6):913-20.
2010: James Brian Byrd; A Woodard-Grice; E Stone; A Lucisano; H Schaefer; Chang Yu; A E Eyler; N E Salloum; Nancy Brown
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use.
Allergy 2010;65(11):1381-7.
2010: Annis Marney; Siri Kunchakarra; Loretta Byrne; Nancy Brown
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
Hypertension 2010;56(4):728-33.
2010: Nancy Brown
Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.
Therapeutic advances in cardiovascular disease 2010;4(5):315-24.
2010: Patricia C Underwood; Bei Sun; Jonathan S Williams; Luminita H Pojoga; Bindu Chamarthi; Jessica Lasky-Su; Benjamin A Raby; Paul N Hopkins; Xavier Jeunemaitre; Nancy Brown; Gail K Adler; Gordon H Williams
The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study.
The Journal of clinical endocrinology and metabolism 2010;95(9):E75-9.
2010: Alencia V Woodard-Grice; Amelia C Lucisano; James B Byrd; Elizabeth R Stone; William H Simmons; Nancy Brown
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.
Pharmacogenetics and genomics 2010;20(9):532-6.
2010: Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy Brown; Francois Marceau; Benjamin Westenberger
Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.
Biomaterials 2010;31(22):5741-8.
2010: Pete Fong; Diana M Stafforini; Nancy Brown; Mias Pretorius
Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanism.
Free radical biology & medicine 2010;49(2):301-5.
2010: Kimberly C Gilbert; Nancy Brown
Aldosterone and inflammation.
Current opinion in endocrinology, diabetes, and obesity 2010;17(3):199-204.
2010: Aditi R Saxena; S Ananth Karumanchi; Nancy Brown; Caroline M Royle; Thomas F McElrath; Ellen W Seely
Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy.
Hypertension 2010;55(5):1239-45.
2010: Mias Pretorius; Nancy Brown
Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
The Journal of pharmacology and experimental therapeutics 2010;332(1):291-7.
2009: Nancy Brown; Mias Pretorius
Letter by Brown and Pretorius regarding article, "effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients".
Circulation 2009;120(19):e159; author reply e160.
2009: Simon Body; Charles Collard; Stanton K Shernan; Amanda A Fox; Kuang-Yu Liu; Marylyn Ritchie; Tjörvi E Perry; Jochen Muehlschlegel; Sary F Aranki; Brian S Donahue; Mias Pretorius; Juan-Carlos Estrada; Patrick T Ellinor; Christopher Newton-Cheh; Christine E Seidman; J G Seidman; Daniel S Herman; Peter Lichtner; Thomas Meitinger; Arne Pfeufer; Stefan Kääb; Nancy Brown; Dan Mark Roden; Dawood Darbar
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery.
Circulation. Cardiovascular genetics 2009;2(5):499-506.
2009: Annis M Marney; Ji Ma; James M Luther; T Alp Ikizler; Nancy Brown
Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis.
Journal of the American Society of Nephrology : JASN 2009;20(10):2246-52.
2009: Nancy Brown; Stuart Byiers; David Carr; Mario Maldonado; Barbara Ann Warner
Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.
Hypertension 2009;54(3):516-23.
2009: William B Lea; Eun Soo Kwak; James M Luther; Susan M Fowler; Zuofei Wang; Ji Ma; Agnes B Fogo; Nancy Brown
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
Kidney international 2009;75(9):936-44.
2009: Kevin D Hill; Aaron W Eckhauser; Annis Marney; Nancy Brown
Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome.
Diabetes care 2009;32(5):857-9.
2009: James M Luther; Zuofei Wang; Ji Ma; Natalia Makhanova; Hyung-Suk Kim; Nancy Brown
Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta.
Endocrinology 2009;150(5):2229-36.
2009: Nancy Brown
Salt in the wound.
Journal of the American Society of Nephrology : JASN 2009;20(1):5-6.
2008: John A Schoenhard; F W Asselbergs; K A Poku; S A Stocki; S Gordon; Douglas E Vaughan; Nancy Brown; Jason Moore; scott williams
Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.
Human genetics 2008;124(5):479-88.
2008: Gregory A Fleming; Katherine T Murray; Chang Yu; John G Byrne; James P Greelish; Michael R Petracek; Steven J Hoff; Stephen K Ball; Nancy Brown; Mias Pretorius
Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.
Circulation 2008;118(16):1619-25.
2008: Abigail Brown; Jason D Morrow; Lee E Limbird; Daniel W Byrne; Steven G Gabbe; Jeffrey R Balser; Nancy Brown
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes.
Academic medicine : journal of the Association of American Medical Colleges 2008;83(10):969-75.
2008: James V Gainer; Michael Lipkowitz; Chang Yu; Michael R Waterman; Elliott P Dawson; Jorge H Capdevila; Nancy Brown
Association of a CYP4A11 variant and blood pressure in black men.
Journal of the American Society of Nephrology : JASN 2008;19(8):1606-12.
2008: Mias Pretorius; Gary P Van Guilder; Raul J Guzman; James M Luther; Nancy Brown
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.
Hypertension 2008;51(4):1190-6.
2008: Cheryl L Laffer; James V Gainer; Michael R Waterman; Jorge H Capdevila; Michal Laniado-Schwartzman; Alberto Nasjletti; Nancy Brown; Fernando Elijovich
The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension.
Hypertension 2008;51(3):767-72.
2008: Gary P Van Guilder; Mias Pretorius; James M Luther; James Brian Byrd; Kevin Hill; James V Gainer; Nancy Brown
Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Hypertension 2008;51(2):454-9.
2008: Nancy Brown
Aldosterone and vascular inflammation.
Hypertension 2008;51(2):161-7.
2008: James Brian Byrd; Karine Touzin; Saba Sile; James V Gainer; Chang Yu; John Nadeau; Albert Adam; Nancy Brown
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
Hypertension 2008;51(1):141-7.
2008: Mias Pretorius; James V Gainer; G P Van Guilder; E B Coelho; James M Luther; P Fong; D D Rosenbaum; Hector A Malave; Chang Yu; Marylyn Ritchie; Douglas E Vaughan; Nancy Brown
The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.
Clinical pharmacology and therapeutics 2008;83(1):122-9.
2007: Saba Sile; Niloufar B Gillani; Digna R Velez; Carlos G Vanoye; Chang Yu; Loretta M Byrne; James V Gainer; Nancy Brown; scott williams; Alfred L George
Functional BSND variants in essential hypertension.
American journal of hypertension 2007;20(11):1176-1182.
2007: Mias Pretorius; Brian S Donahue; Chang Yu; James P Greelish; Dan Mark Roden; Nancy Brown
Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass.
Circulation 2007;116(11 Suppl):I1-7.
2007: Annis M Marney; Nancy Brown
Aldosterone and end-organ damage.
Clinical science (London, England : 1979) 2007;113(6):267-78.
2007: James Brian Byrd; Ajai Shreevatsa; Pradeep Putlur; Denis Foretia; Laurie McAlexander; Tuhin Sinha; Mark D Does; Nancy Brown
Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema.
The Journal of allergy and clinical immunology 2007;120(2):403-8.
2007: Nancy Brown; J Bradford; Z Wang; W Lea; L Ma; Ji Ma; Douglas E Vaughan; Agnes B Fogo
Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.
Kidney international 2007;72(1):72-81.
2007: Bindu Chamarthi; Nikheel S Kolatkar; Steven C Hunt; Jonathan S Williams; Ellen W Seely; Nancy Brown; Laine J Murphey; Xavier Jeunemaitre; Gordon H Williams
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension.
The Journal of clinical endocrinology and metabolism 2007;92(4):1340-6.
2007: Olga Gumieniak; Todd S Perlstein; Jonathan S Williams; Paul N Hopkins; Nancy Brown; Benjamin A Raby; Gordon H Williams
Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
Hypertension 2007;49(3):461-6.
2007: Jean Lefebvre; Ayumi Shintani; Tebeb Gebretsadik; Jeffery R Petro; Laine J Murphey; Nancy Brown
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
The Journal of pharmacology and experimental therapeutics 2007;320(3):1261-7.
2007: James A S Muldowney; Corrie A Painter; Elaine Sanders-Bush; Nancy Brown; Douglas E Vaughan
Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.
Thrombosis and haemostasis 2007;97(2):263-71.
2007: scott williams; Shelli Stocki; Lan Jiang; Kwabena Brew; Seth Gordon; Douglas E Vaughan; Nancy Brown; Kwabena A Poku; Jason Moore
A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.
Ethnicity & disease 2007;17(3):492-7.
2006: James M Luther; James V Gainer; Laine J Murphey; Chang Yu; Douglas E Vaughan; Jason D Morrow; Nancy Brown
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
Hypertension 2006;48(6):1050-7.
2006: James Brian Byrd; Albert Adam; Nancy Brown
Angiotensin-converting enzyme inhibitor-associated angioedema.
Immunology and allergy clinics of North America 2006;26(4):725-37.
2006: Luminita Pojoga; Nikheel S Kolatkar; Jonathan S Williams; Todd S Perlstein; Xavier Jeunemaitre; Nancy Brown; Paul N Hopkins; Benjamin A Raby; Gordon H Williams
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension.
Hypertension 2006;48(5):892-900.
2006: Laine J Murphey; Hector A Malave; Jeff Petro; Italo Biaggioni; Daniel W Byrne; Douglas E Vaughan; James M Luther; Mias Pretorius; Nancy Brown
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1287-92.
2006: Nancy Brown
Blood pressure reduction and tissue-type plasminogen activator release.
Hypertension 2006;47(4):648-9.
2006: Ji Ma; Alec D Weisberg; Jane P Griffin; Douglas E Vaughan; Agnes B Fogo; Nancy Brown
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
Kidney international 2006;69(6):1064-72.
2006: Nancy Brown; James A S Muldowney; Douglas E Vaughan
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
Hypertension 2006;47(3):441-8.
2006: J S Williams; Gordon H Williams; Annaswamy Raji; X Jeunemaitre; Nancy Brown; P N Hopkins; Paul R Conlin
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.
Journal of human hypertension 2006;20(2):129-36.
2006: Alison A Motsinger; Brian S Donahue; Nancy Brown; Dan Mark Roden; Marylyn Ritchie
Risk factor interactions and genetic effects associated with post-operative atrial fibrillation.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2006;():584-95.
2005: Mias Pretorius; Frank G Scholl; Julie A McFarlane; Laine J Murphey; Nancy Brown
A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Clinical pharmacology and therapeutics 2005;78(5):477-85.
2005: Jean-Claude Aldigier; Talerngsak Kanjanbuch; Li-Jun Ma; Nancy Brown; Agnes B Fogo
Regression of existing glomerulosclerosis by inhibition of aldosterone.
Journal of the American Society of Nephrology : JASN 2005;16(11):3306-14.
2005: Mias Pretorius; James M Luther; Laine J Murphey; Douglas E Vaughan; Nancy Brown
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(11):2435-40.
2005: Qing Ling Duan; Borzoo Nikpoor; Marie-Pierre Dube; Giuseppe Molinaro; Inge A Meijer; Patrick Dion; Daniel Rochefort; Judith Saint-Onge; Leah Flury; Nancy Brown; James V Gainer; Jean-Lucien Rouleau; Angelo Agostoni; Massimo Cugno; Pierre Simon; Pierre Clavel; Jacky Potier; Bassem Wehbe; Seddik Benarbia; Julien Marc-Aurele; Jacques Chanard; Tatiana Foroud; Albert Adam; Guy Rouleau
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.
American journal of human genetics 2005;77(4):617-26.
2005: Baogang J Xu; Yu Shyr; Xiubin Liang; Li-Jun Ma; Ellen M Donnert; Jeremy D Roberts; Xueqiong Zhang; Valentina Kon; Nancy Brown; Richard M Caprioli; Agnes B Fogo
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms.
Journal of the American Society of Nephrology : JASN 2005;16(10):2967-75.
2005: Marie Eve Moreau; Nancy Garbacki; Giuseppe Molinaro; Nancy Brown; Francois Marceau; Albert Adam
The kallikrein-kinin system: current and future pharmacological targets.
Journal of pharmacological sciences 2005;99(1):6-38.
2005: Ji Ma; Francisco Albornoz; Chang Yu; Daniel W Byrne; Douglas E Vaughan; Nancy Brown
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
Hypertension 2005;46(2):313-20.
2005: Nancy Brown
Aldosterone and end-organ damage.
Current opinion in nephrology and hypertension 2005;14(3):235-41.
2005: Alec D Weisberg; Francisco Albornoz; Jane P Griffin; David L Crandall; Hassan Elokdah; Agnes B Fogo; Douglas E Vaughan; Nancy Brown
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):365-71.
2005: James V Gainer; Aouatef Bellamine; Elliott P Dawson; Kristie E Womble; Sarah W Grant; Yarong Wang; L Adrienne Cupples; Chao-Yu Guo; Serkalem Demissie; Christopher J O'Donnell; Nancy Brown; Michael R Waterman; Jorge H Capdevila
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.
Circulation 2005;111(1):63-9.
2004: James A S Muldowney; Stephen N Davis; Douglas E Vaughan; Nancy Brown
NO synthase inhibition increases aldosterone in humans.
Hypertension 2004;44(5):739-45.
2004: Mias Pretorius; Julie A McFarlane; Douglas E Vaughan; Nancy Brown; Laine J Murphey
Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
Clinical pharmacology and therapeutics 2004;76(4):379-87.
2004: Todd S Perlstein; Olga Gumieniak; Paul N Hopkins; Laine J Murphey; Nancy Brown; Gordon H Williams; Norman K Hollenberg; Naomi D L Fisher
Uric acid and the state of the intrarenal renin-angiotensin system in humans.
Kidney international 2004;66(4):1465-70.
2004: Olga Gumieniak; Todd S Perlstein; Paul N Hopkins; Nancy Brown; Laine J Murphey; Xavier Jeunemaitre; Norman K Hollenberg; Gordon H Williams
Thyroid function and blood pressure homeostasis in euthyroid subjects.
The Journal of clinical endocrinology and metabolism 2004;89(7):3455-61.
2004: Paul M Ridker; Nancy Brown; Douglas E Vaughan; David G Harrison; Jawahar L Mehta
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.
Circulation 2004;109(25 Suppl 1):IV6-19.
2004: Laine J Murphey; Wendy K Eccles; Gordon H Williams; Nancy Brown
Loss of sodium modulation of plasma kinins in human hypertension.
The Journal of pharmacology and experimental therapeutics 2004;308(3):1046-52.
2004: Li-Jun Ma; Su-Li Mao; Kevin L Taylor; Talerngsak Kanjanabuch; Youfei Guan; YaHua Zhang; Nancy Brown; Larry L Swift; Owen P McGuinness; David H Wasserman; Douglas E Vaughan; Agnes B Fogo
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.
Diabetes 2004;53(2):336-46.
2004: Marshall Summar; James V Gainer; Mias Pretorius; Hector A Malave; Stephanie Harris; Lynn D Hall; Alec D Weisberg; Douglas E Vaughan; Brian W Christman; Nancy Brown
Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.
Hypertension 2004;43(2):186-91.
2003: Mias Pretorius; Laine J Murphey; Julie A McFarlane; Douglas E Vaughan; Nancy Brown
Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Circulation 2003;108(25):3079-83.
2003: Mesut Eren; Corrie A Painter; Linda A Gleaves; John A Schoenhard; James B Atkinson; Nancy Brown; Douglas E Vaughan
Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2389-96.
2003: Laine J Murphey; Jason D Morrow; Pairunyar Sawathiparnich; Gordon H Williams; Douglas E Vaughan; Nancy Brown
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives.
Free radical biology & medicine 2003;35(7):711-8.
2003: Pairunyar Sawathiparnich; Laine J Murphey; Sandeep Kumar; Douglas E Vaughan; Nancy Brown
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.
The Journal of clinical endocrinology and metabolism 2003;88(8):3867-73.
2003: Nancy Brown
Eplerenone: cardiovascular protection.
Circulation 2003;107(19):2512-8.
2003: Mias Pretorius; David Rosenbaum; Douglas E Vaughan; Nancy Brown
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
Circulation 2003;107(4):579-85.
2003: Aouatef Bellamine; Yarong Wang; Michael R Waterman; James V Gainer; Elliott P Dawson; Nancy Brown; Jorge H Capdevila
Characterization of the CYP4A11 gene, a second CYP4A gene in humans.
Archives of biochemistry and biophysics 2003;409(1):221-7.
2002: Nancy Brown; Sandeep Kumar; Corrie A Painter; Douglas E Vaughan
ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
Hypertension 2002;40(6):859-65.
2002: Sarah Meredith; Penny Feldman; Dennee Frey; Lisa Giammarco; Kathi Hall; Kristina Arnold; Nancy Brown; Wayne A Ray
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial.
Journal of the American Geriatrics Society 2002;50(9):1484-91.
2002: Nancy Brown; Douglas E Vaughan; Agnes B Fogo
The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease.
Seminars in nephrology 2002;22(5):399-406.
2002: David A Rosenbaum; Mias Pretorius; James V Gainer; Daniel Byrne; Laine J Murphey; Corrie A Painter; Douglas E Vaughan; Nancy Brown
Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(6):1023-8.
2002: Koichi Kaikita; John A Schoenhard; Corrie A Painter; Robert T Ripley; Nancy Brown; Agnes B Fogo; Douglas E Vaughan
Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
Journal of molecular and cellular cardiology 2002;34(6):617-27.
2002: Nancy Brown; Douglas E Vaughan; Agnes B Fogo
Aldosterone and PAI-1: implications for renal injury.
Journal of nephrology 2002;15(3):230-5.
2002: Mias Pretorius; David A Rosenbaum; Jean Lefebvre; Douglas E Vaughan; Nancy Brown
Smoking impairs bradykinin-stimulated t-PA release.
Hypertension 2002;39(3):767-71.
2002: Jean Lefebvre; Laine J Murphey; Tina V Hartert; Ru Jiao Shan; William H Simmons; Nancy Brown
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema.
Hypertension 2002;39(2 Pt 2):460-4.
2002: Pairunyar Sawathiparnich; Sandeep Kumar; Douglas E Vaughan; Nancy Brown
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans.
The Journal of clinical endocrinology and metabolism 2002;87(2):448-52.
2002: Nancy Brown; Amira Abbas; Daniel Byrne; John A Schoenhard; Douglas E Vaughan
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Circulation 2002;105(3):304-9.
2001: Koichi Kaikita; Agnes B Fogo; L Ma; John A Schoenhard; Nancy Brown; Douglas E Vaughan
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
Circulation 2001;104(7):839-44.
2001: Sarah Meredith; Penny Hollander Feldman; Dennee Frey; Kathi Hall; K Arnold; Nancy Brown; Wayne A Ray
Possible medication errors in home healthcare patients.
Journal of the American Geriatrics Society 2001;49(6):719-24.
2001: Nancy Brown; Laine J Murphey; N Srikuma; N Koschachuhanan; G H Williams; Douglas E Vaughan
Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(6):1071-7.
2001: T Wilsdorf; James V Gainer; Laine J Murphey; Douglas E Vaughan; Nancy Brown
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
Hypertension 2001;37(4):1136-40.
2000: James V Gainer; Nancy Brown; Magdalena Bachvarova; Luc Bastien; I Maltais; Francois Marceau; Dimcho Bachvarov
Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.
American journal of hypertension 2000;13(12):1268-73.
2000: Laine J Murphey; Sandeep Kumar; Nancy Brown
Endogenous bradykinin and the renin and pressor responses to furosemide in humans.
The Journal of pharmacology and experimental therapeutics 2000;295(2):644-8.
2000: Nancy Brown; James V Gainer; Laine J Murphey; Douglas E Vaughan
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Circulation 2000;102(18):2190-6.
2000: Nancy Brown; Shinya Nakamura; L Ma; Ikuko Nakamura; Ellen M Donnert; M Freeman; Douglas E Vaughan; Agnes B Fogo
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
Kidney international 2000;58(3):1219-27.
2000: Laine J Murphey; James V Gainer; Douglas E Vaughan; Nancy Brown
Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin.
Circulation 2000;102(8):829-32.
2000: Laine J Murphey; David L Hachey; John A Oates; J D Morrow; Nancy Brown
Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite.
The Journal of pharmacology and experimental therapeutics 2000;294(1):263-9.
2000: Hong-Guang Xie; C Michael Stein; Richard B Kim; James V Gainer; Gbenga G Sofowora; Victor Dishy; Nancy Brown; R E Goree; Jonathan L Haines; Alastair J J Wood
Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.
Clinical pharmacology and therapeutics 2000;67(6):670-5.
2000: Nancy Brown; Douglas E Vaughan
Prothrombotic effects of angiotensin.
Advances in internal medicine 2000;45():419-29.
2000: Nancy Brown; K S Kim; Y Q Chen; Lewis S Blevins; J H Nadeau; Steven G Meranze; Douglas E Vaughan
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
The Journal of clinical endocrinology and metabolism 2000;85(1):336-44.
2000: K S Kim; Sandeep Kumar; W H Simmons; Nancy Brown
Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
The Journal of pharmacology and experimental therapeutics 2000;292(1):295-8.
1999: Hong-Guang Xie; Richard B Kim; C Michael Stein; James V Gainer; Nancy Brown; Alastair J J Wood
Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension.
Pharmacogenetics 1999;9(5):651-6.
1999: Charles Blais; Jean-Lucien Rouleau; Nancy Brown; Yves Lepage; D Spence; C Munoz; J Friborg; David Geadah; Nicole Gervais; Albert Adam
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
Immunopharmacology 1999;43(2-3):293-302.
1999: Hong-Guang Xie; C Michael Stein; Richard B Kim; Zhou-Sheng Xiao; Nan He; Hong-Hao Zhou; James V Gainer; Nancy Brown; Jonathan L Haines; Alastair J J Wood
Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.
Pharmacogenetics 1999;9(4):511-6.
1999: Nancy Brown; MA Agirbasli; Douglas E Vaughan
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Hypertension 1999;34(2):285-90.
1999: Nancy Brown; James V Gainer; C Michael Stein; Douglas E Vaughan
Bradykinin stimulates tissue plasminogen activator release in human vasculature.
Hypertension 1999;33(6):1431-5.
1998: Nancy Brown; MA Agirbasli; G H Williams; W R Litchfield; Douglas E Vaughan
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Hypertension 1998;32(6):965-71.
1998: James V Gainer; Jason D Morrow; A Loveland; D J King; Nancy Brown
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
The New England journal of medicine 1998;339(18):1285-92.
1998: Nancy Brown; Douglas E Vaughan
Angiotensin-converting enzyme inhibitors.
Circulation 1998;97(14):1411-20.
1998: S K Gandhi; James V Gainer; D King; Nancy Brown
Gender affects renal vasoconstrictor response to Ang I and Ang II.
Hypertension 1998;31(1):90-6.
1997: James V Gainer; Tracy E Hunley; Valentina Kon; J H Nadeau; James A S Muldowney; Nancy Brown
Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant.
Biochemistry and molecular biology international 1997;43(1):227-31.
1997: Nancy Brown; M Snowden; Marie R Griffin
Recurrent angiotensin-converting enzyme inhibitor--associated angioedema.
JAMA : the journal of the American Medical Association 1997;278(3):232-3.
1997: Nancy Brown; J H Nadeau; Douglas E Vaughan
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.
Thrombosis and haemostasis 1997;77(3):522-5.
1996: S K Gandhi; D H Ryder; Nancy Brown
Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
Hypertension 1996;28(6):961-6.
1996: Nancy Brown; D Ryder; James V Gainer; Jason D Morrow; John Nadeau
Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
The Journal of pharmacology and experimental therapeutics 1996;279(2):703-12.
1996: Nancy Brown; Douglas E Vaughan
The Renin-Angiotensin and fibrinolytic systems co-conspirators in the pathogenesis of ischemic cardiovascular disease.
Trends in cardiovascular medicine 1996;6(7):239-43.
1996: James V Gainer; J H Nadeau; D Ryder; Nancy Brown
Increased sensitivity to bradykinin among African Americans.
The Journal of allergy and clinical immunology 1996;98(2):283-7.
1996: Nancy Brown; Wayne A Ray; M Snowden; Marie R Griffin
Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.
Clinical pharmacology and therapeutics 1996;60(1):8-13.
1996: Tracy E Hunley; B A Julian; John A Phillips; Marshall Summar; H Yoshida; R G Horn; Nancy Brown; A Fogo; Iekuni Ichikawa; Valentina Kon
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Kidney international 1996;49(2):571-7.
1994: V C Daniel; T A Minton; Nancy Brown; J H Nadeau; Jason D Morrow
Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical applications 1994;653(2):117-22.
1993: Nancy Brown; D Ryder; John Nadeau
Caffeine attenuates the renal vascular response to angiotensin II infusion.
Hypertension 1993;22(6):847-52.
1991: Nancy Brown; D Ryder; Robert A Branch
A pharmacodynamic interaction between caffeine and phenylpropanolamine.
Clinical pharmacology and therapeutics 1991;50(4):363-71.
1991: Nancy Brown; J Porter; D Ryder; Robert A Branch
Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine.
The Journal of pharmacology and experimental therapeutics 1991;256(1):56-61.